| Select | PubMed ID | Description |
| 8613635 | J Allergy Clin Immunol. 1996 Mar;97(3):781-7.
Immunologic characterization of purified recombinant timothy grass pollen (Phleum
pratense) allergens (Phl p 1, Phl p2, Phl p 5).
Vrtala S(1), Susani M, Sperr WR, Valent P, Laffer S, Dolecek C, Kraft D, Valenta
R.
|
| 10382766 | Eur J Immunol. 1999 Jun;29(6):2026-36.
Induction of antibody responses to new B cell epitopes indicates vaccination
character of allergen immunotherapy.
Ball T(1), Sperr WR, Valent P, Lidholm J, Spitzauer S, Ebner C, Kraft D, Valenta
R.
|
| 10428753 | FASEB J. 1999 Aug;13(11):1277-90.
B cell epitopes of the major timothy grass pollen allergen, phl p 1, revealed by
gene fragmentation as candidates for immunotherapy.
Ball T(1), Fuchs T, Sperr WR, Valent P, Vangelista L, Kraft D, Valenta R.
|
| 11421902 | Allergy. 2001 Jun;56(6):548-52.
Diagnostic evaluation of grass- and birch-allergic patients with oral allergy
syndrome.
Anhoej C(1), Backer V, Nolte H.
|
| 11511525 | FASEB J. 2001 Sep;15(11):2042-4. Epub 2001 Jul 24.
Nonanaphylactic synthetic peptides derived from B cell epitopes of the major
grass pollen allergen, Phl p 1, for allergy vaccination.
Focke M(1), Mahler V, Ball T, Sperr WR, Majlesi Y, Valent P, Kraft D, Valenta R.
|
| 17291855 | J Allergy Clin Immunol. 2007 Feb;119(2):384-90. Epub 2006 Nov 7.
Molecular determinants of allergen-induced effector cell degranulation.
Gieras A(1), Focke-Tejkl M, Ball T, Verdino P, Hartl A, Thalhamer J, Valenta R.
|
| 17393727 | Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2006;(95):84-8;
discussion 88-90, 100-4.
Immune reactivity of candidate reference materials.
Fernandez-Rivas M(1), Aalbers M, Fötisch K, de Heer P, Notten S, Vieths S, van
Ree R.
|
| 19243361 | Allergy. 2009 Apr;64(4):569-80. doi: 10.1111/j.1398-9995.2008.01910.x. Epub 2009
Feb 19.
Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for
allergy vaccination.
Ball T(1), Linhart B, Sonneck K, Blatt K, Herrmann H, Valent P, Stoecklinger A,
Lupinek C, Thalhamer J, Fedorov AA, Almo SC, Valenta R.
|
| 19414783 | J Immunol. 2009 May 15;182(10):6298-306. doi: 10.4049/jimmunol.0713622.
A combination vaccine for allergy and rhinovirus infections based on
rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major
timothy grass pollen allergen Phl p 1.
Edlmayr J(1), Niespodziana K, Linhart B, Focke-Tejkl M, Westritschnig K,
Scheiblhofer S, Stoecklinger A, Kneidinger M, Valent P, Campana R, Thalhamer J,
Popow-Kraupp T, Valenta R.
|
| 20558998 | Int Arch Allergy Immunol. 2010;153(4):323-34. doi: 10.1159/000316343. Epub 2010
Jun 17.
Effect on cell surface markers following allergen-induced desensitization of
human whole-blood basophils.
Lund G(1), Jacobi H, Skov PS, Holm J, Lund K.
|
| 23182706 | Immunobiology. 2013 Jun;218(6):884-91. doi: 10.1016/j.imbio.2012.10.008. Epub
2012 Oct 26.
Passive immunization with allergen-specific IgG antibodies for treatment and
prevention of allergy.
Flicker S(1), Linhart B, Wild C, Wiedermann U, Valenta R.
|
| 23761636 | J Immunol. 2013 Jul 15;191(2):551-60. doi: 10.4049/jimmunol.1202051. Epub 2013
Jun 12.
Phl p 1-specific human monoclonal IgE and design of a hypoallergenic group 1
grass pollen allergen fragment.
Levin M(1), Rydnert F, Källström E, Tan LW, Wormald PJ, Lindstedt M, Greiff L,
Ohlin M.
|
